Related Experiment Video
Updated: Feb 1, 2026

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025
[Expression Changes of Serum Transferrin Receptor and Its Mechanism in Children with Acute Leukemia]
1Department of Clinical Laboratorial Examination, Foshan first people's Hospital, Foshan 528000, Guangdong Province,China.E-mail:chenshean56@163.com.
Insights
Serum transferrin receptor (sTFR) levels are elevated in children with acute leukemia (AL). Downregulating transferrin receptor (TFR) gene expression inhibits leukemia cell proliferation and division, offering a potential therapeutic strategy for AL.
Area of Science:
- Hematology
- Molecular Biology
- Oncology
Background:
- Acute leukemia (AL) is a significant health concern in children.
- Serum transferrin receptor (sTFR) is a marker associated with cell proliferation and iron metabolism.
- Understanding the role of sTFR in pediatric AL is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the expression changes of serum transferrin receptor (sTFR) in children with acute leukemia (AL).
- To explore the mechanism underlying sTFR expression in AL.
- To evaluate the effect of transferrin receptor (TFR) gene silencing on leukemia cell proliferation and cell cycle.
Main Methods:
- Comparative analysis of sTFR levels in pediatric AL patients and healthy controls.
- Detection of TFR mRNA and protein expression in peripheral blood leukemic cells.
- RNA interference (siRNA) to silence TFR genes in leukemia cell lines (KG-1a and TCHu147).
- MTT assay and flow cytometry to assess cell proliferation and cell cycle distribution.
- Western blot to analyze cyclin levels post-TFR gene silencing.
Main Results:
- Children with AL exhibited significantly higher sTFR levels compared to healthy controls.
- Elevated TFR mRNA and protein expression were observed in leukemic cells from AL patients.
- sTFR levels correlated with white blood cell count, leukemic cell burden, hepcidin levels, and risk grade in AL patients.
- TFR gene silencing significantly inhibited the proliferation of KG-1a and TCHu147 cells.
- Flow cytometry revealed an increased G0/G1 phase cell ratio and a decreased G2/M phase cell ratio in TFR-silenced leukemia cells.
Conclusions:
- Peripheral blood leukemic cells in AL patients synthesize increased TFR protein, leading to elevated sTFR levels.
- Downregulating TFR gene expression effectively interferes with leukemia cell division.
- Targeting TFR presents a promising therapeutic strategy for pediatric acute leukemia.
Objective:
To investigate the expression changes of serum transferrin receptor(sTFR) and its related mechanism in children with acute leukemia(AL).
Methods:
Forty-six children with acute leukemia treated in our hospital from June 2016 to June 2017 were selected and enrolled in the AL group, 40 healthy children were enrolled in the control group. The related clinical data were recorded, including age, sex and CNSL level. RNA interference technology was used to silence TFR genes of KG-1a and TCHu147 cells, MTT method and flow cytometry were used to analyze the effect of TFR gene on proliferation and cell cycle of KG-1a cells and TCHu147 cells. Western blot was used to detect the level of cyclin related to leukemic cells after siRNA interference.
Results:
The level of sTFR in AL patients was significantly higher than that of healthy people (P<0.05). The mRNA and protein expression levels of TFR in peripheral blood leukemic cells were all higher than those in healthy people (P<0.05). The level of sTFR closely related to the white blood cell(WBC) count, the proportion and absolute number of leukemic cells, hepcidin(Hepc) level, and risk grade in AL patients (P<0.05). The proliferation ability of KG-1a and TCHu147 cells after TFR siRNA interference was significantly inhibited (P<0.05). Fow cytometry showed that after the TFR siRNA interference, the ratio of KG-1a and TCHu147 cells in G0/G1 phase was 62.51%±5.39% and 63.37%±4.27%, respectively, which increased significantly as compared with the blank and negative control group (P<0.05); the ratio of KG-1a and TCHu147 in G2/M phase was 5.74%±1.34% and 7.37%±1.56%, respectively, which significantly decreased as compared with the blank control and the negative control group (P<0.05).
Conclusion:
The peripheral blood leukemic cells of AL patients can synthesize more TFR protein, lead into the increase of sTFR level. It can effectively interfere the division of leukemia cells by downregulating the expression of TFR gene.
Related Concept Videos
The Early Endosome: Endocytosis of Transferrin
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Transducer Mechanism: G Protein–Coupled Receptors
GPCRs are also called heptahelical,...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Internal Receptors
Ligand-Gated Ion Channel Receptor: Gating Mechanism

